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Abstract  
Macrophages are a diverse group of phagocytic cells acting in host protection 
against stress, injury, and pathogens. Here, we show that the scavenger receptor SR-A6 is 
an entry receptor for human adenoviruses in murine alveolar macrophage-like MPI cells, 
and important for production of type I interferon. Scavenger receptors contribute to the 
clearance of endogenous proteins, lipoproteins and pathogens. Knockout of SR-A6 in MPI 
cells, anti-SR-A6 antibody or the soluble extracellular SR-A6 domain reduced adenovirus 
type-C5 (HAdV-C5) binding and transduction. Expression of murine SR-A6, and to a lower 
extent human SR-A6 boosted virion binding to human cells and transduction. Virion 
clustering by soluble SR-A6 and proximity localization with SR-A6 on MPI cells suggested 
direct adenovirus interaction with SR-A6. Deletion of the negatively charged hypervariable 
region 1 (HVR1) of hexon reduced HAdV-C5 binding and transduction, implying that the 
viral ligand for SR-A6 is hexon. SR-A6 facilitated macrophage entry of HAdV-B35 and 
HAdV-D26, two important vectors for transduction of hematopoietic cells and human 
vaccination. The study highlights the importance of scavenger receptors in innate immunity 
against human viruses.   
Author summary 
Macrophages are a diverse group of phagocytic cells acting in host protection 
against stress, injury, and pathogens. They phenotypically and functionally adapt to their 
local environment, for example, peritoneal macrophages are distinct from brain-resident 
microglia, from liver-resident Kupffer cells or lung macrophages in the lung. Airway 
macrophages are among the first cells to encounter human respiratory viruses, such as 
adenoviruses. They release pro-inflammatory cytokines, kill pathogens, present antigens, 
and restore tissues. Yet, interactions of viruses with lung macrophages are poorly 
understood, and it is unclear, how they lead to infection or virus clearance. Here we 
identified the murine scavenger receptor SR-A6 as a receptor for a subset of human 
adenoviruses on alveolar macrophage-like cells, so-called MPI cells. Scavenger receptors 
comprise a large family of trans-membrane proteins, and contribute to the clearance of 
endogenous proteins, lipoproteins and pathogens. In a series of robust experimentation, we 
show that adenoviruses use SR-A6 as an entry receptor for infection of MPI cells, and 
production of type I interferon. MPI cells are non-transformed, self-renewing macrophages 
derived from fetal murine liver, and closely resemble adult alveolar macrophages. The 
results demonstrate that SR-A6 binds virions on the surface of alveolar macrophage-like 
cells, and leads to infection.  
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Introduction 
Macrophages are a diverse population of innate immune cells. They function as a 
first-line defense against pathogens, including viruses. Most tissues contain macrophages, 
and these macrophages differ by origin, repertoire of surface receptors and transcriptional 
regulation of many genes [1]. Macrophages are seeded into their tissue-resident 
environment during embryogenesis or differentiate from monocytes and develop plasticity 
and function in response to signals from their microenvironment [reviewed in 2, 3, 4]. 
Macrophages contain a broad array of surface receptors for recognition and engulfment of 
pathogens, including fungi, bacteria and viruses [5-8]. Different studies have shown that 
murine cytomegalovirus (MCMV), vaccinia virus (VacV) or human adenovirus (HAdV) 
infections induce the production of type I interferon (IFN) [9, 10]. A key element of how 
macrophages function and elicit inflammatory signaling is that they bind to pathogens by 
their cell surface receptors.  
An important and widely expressed class of macrophage surface receptors are 
scavenger receptors (SRs). SRs constitute a large family of structurally diverse cell surface 
receptors, and span the membrane once or twice. SRs interact with and mediate uptake of 
a wide range of ligands, such as modified and non-modified self-molecules, non-opsonized 
particles and microbial ligands [11, 12]. On macrophages, SRs recognize a broad range of 
ligands, and are important for the clearance of foreign particulate material [12-14]. For 
example, human and murine SR-A6 have been implicated in infection of epithelial cells with 
herpes simplex virus type 1 (HSV-1), and SR-A1 and SR-F1/2 (SREC-1) are surface 
receptor candidates for HAdV-C5 on Kupffer cells and liver sinusoidal endothelial cells [15-
18].  
A virus receptor on the cell surface is a gatekeeper viral invasion into the host, 
triggering virus production or destruction. The receptor makes direct contact with the virus 
particle, the virion. The outer structure of a virion consists of repetitively arranged proteins, 
and in case of enveloped viruses also lipids and sugars. This enables the engagement of 
multiple receptor molecules to a virion, the recruitment of host signaling molecules, and 
leads to the formation of an endocytic pit, and virion uptake into an endosome [19-22]. 
Receptor binding to virions also initiates structural changes in the particle which, together 
with additional cues from the cell, enable the virus to penetrate into the cytosol [22-24]. For 
example, the coxsackie adenovirus receptor (CAR) mediates initial attachment of species A 
and C HAdVs to non-immune cells [25-27], distinct from the membrane cofactor protein 
CD46, or desmoglein-2, which are the main receptors for species D and B viruses, 
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respectively [28-30]. CAR engages retrograde acto-myosin mediated transport and exerts 
mechanical stress on HAdV-C5 against the holding force of the secondary integrin 
receptors, which leads to the exposure of the membrane lytic protein of the virion [31, 32]. 
CAR, CD46 and DSG-2 interactions with HAdV are mediated by the globular head domain 
(knob) of the fiber which protrudes from the vertex of the icosahedral virion [33]. Yet, CAR 
and DSG-2 are not expressed on macrophages, and although CD46 is a ubiquitously 
expressed protein in humans, its expression in mouse is restricted to testis [34].  
HAdVs are non-enveloped, double stranded DNA viruses. They replicate in the host 
cell nucleus. Their outer surface is composed of three main proteins, hexon, penton base 
and fiber. Penton base and fiber localize to the capsid vertices, whereas the structural 
framework of the capsid is formed by hexons [35, 36]. HAdVs are classified into seven 
species A to G with more than 50 serotypes, and nearly 70 bioinformatically defined types 
[37]. HAdV infections in immuno-competent hosts manifest with mild respiratory (HAdV-B, -
C, -E), ocular (HAdV-B, -D, -F) or gastrointestinal infections (HAdV-F). The widespread 
application of HAdV-based vectors in gene therapy, cancer gene therapy and vaccination 
enhances the medical importance of these viruses [38-40].  
HAdV-C5 based toxicity is strongly linked to innate immune responses against the 
virions [10, 41-43]. Macrophages are central actors in these responses. For example, 
intravenous administration of HAdV-C5-derived vectors into mice leads to rapid capture of 
the vector particles by the liver resident macrophages, the Kupffer cells, as well as by the 
spleen marginal zone macrophages and myeloid dendritic cells, and these cells contribute 
to the vector-induced early production of proinflammatory cytokines, such as type I IFNs, 
interleukin-1α (IL-1α), interleukin-6 (IL-6) and tumor necrosis factor (TNF) [10, 44-46] (and 
own unpublished data). Furthermore, lung macrophages capture HAdV-C5-derived vectors 
administered via the respiratory tract and respond with a rapid induction of TNF and IL-6 
[47, 48]. Finally, mouse alveolar macrophage-like MPI cells produce robust levels of 
cytokines upon inoculation with early gene expression defective HAdV-C5_dE1_GFP [49]. 
These acute phase macrophage responses are directly triggered by the incoming virions, 
and critically require interaction of the incoming viral genome with the cytoplasmic DNA 
sensor cyclic GMP-AMP synthase (cGAS) and/or the endosomal DNA sensor Toll-like 
receptor 9 (TLR9) [44, 50-53]. However, virus-host interactions that mediate attachment 
and uptake of adenoviruses into macrophages are incompletely understood.   
In the present study, we made use of the recently developed mouse alveolar 
macrophage-like MPI (MPI-2) cells derived from C57BL/6 (BL6) mice [49] and identified the 
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scavenger receptor SR-A6 (MARCO; macrophage receptor with collagenous structure) as a 
receptor for HAdV-C5. We show that knockdown or knockout of the SR-A6 gene, anti-SR-
A6 antibody or soluble extracellular domain of SR-A6 inhibited binding of HAdV-C5 to MPI-2 
cells and virus-mediated gene transduction. EM studies indicated that the soluble SR-A6 
caused clustering of HAdV-C5 particles, implying that SR-A6 directly interacts with the 
virion. In support of direct SR-A6 interaction with HAdV-C5, proximity ligation assays of 
HAdV-C5 on SR-A6 positive cells demonstrated that cell surface-bound virions were in 
close proximity to SR-A6. Genetic swopping of the negatively charged hypervariable region 
1 (HVR1) of HAdV-C5 hexon with the short HVR1 of HAdV-A31 reduced virus binding and 
virus-mediated gene transduction of MPI-2 cells. HAdV-C5 binding to SR-A6 initiated an 
entry pathway leading to efficient nuclear targeting of the incoming virus, and gene 
transduction. SR-A6 not only supported HAdV-C5 entry and transduction, but also enabled 
HAdV-C2, HAdV-B35 and HAdV-D26 entry into macrophages. Although the human 
orthologue of SR-A6 enhanced virion binding to and transduction of receptor-negative cells, 
it was a weaker receptor for HAdV-C5 than mSR-A6.   
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Results 
SR-A6 is required for HAdV-C5 infection of murine alveolar macrophage-
like MPI-2 cells  
Limited supply of primary tissue macrophages and the sparseness of tissue 
culture models for macrophages has hampered characterization of host molecules that 
facilitate uptake of HAdVs into tissue macrophages. MPI (Max Planck Institute)-2 cells 
are non-transformed, self-renewing alveolar macrophage-like cells derived from 
mouse fetal liver [49], the organ that seeds the precursor cells that later develop into 
lung macrophages [54]. Alveolar macrophages are operationally defined here as those 
macrophages that are recovered from lung lavages. In contrast to bone marrow-
derived macrophages (BMM), robust pro-inflammatory responses to HAdV-C are 
elicited in MPI-2 cells [49]. Likewise, human BMMs are not productively infected with 
HAdV species C although they respond to virions by an inflammatory response [55]. 
This suggests that MPI-2 cells are more susceptible to HAdV-C infection than BMMs. 
Comparison of BMM and MPI-2 transcriptomes indicated that the scavenger receptor 
SR-A6 (MARCO) mRNAs were significantly more abundant in MPI-2 cells than in 
BMMs, whereas other scavenger receptors displayed similar transcript levels in both 
cell types [49, 53]. 
This prompted us to investigate whether SR-A6 could act as a receptor for 
HAdV-C5 in MPI-2 cells. As shown in Fig. 1A, shRNA-mediated knockdown of SR-A6 
in MPI-2 cells significantly reduced GFP transgene expression from the non-replicating 
HAdV-C5_dE1_GFP vector, whereas no reduction in infection efficiency was observed 
upon knockdown of other scavenger receptors expressed in MPI-2 cells, i.e. SR-A1 
(Msr1), SR-B1 (SCAR-B1) or SR-B2 (CD36). Efficient knockdown levels were 
confirmed by qRT-PCR (Fig. 1B). Of note, SR-A6 shRNA reduced SR-A1 and SR-B2 
transcripts, but since both SR-A1 or SR-B2 shRNAs actually boosted HAdV-
C5_dE1_GFP infection despite efficient knockdown of the respective transcripts, SR-
A1 and SR-B2 are unlikely to be connected to the SR-A6 shRNA infection phenotype. 
To exclude seed-mediated off-target effects for the SR-A6 shRNA phenotype, we 
employed the so-called C911 control [56]. In this control, the shRNA bases 9 to 11 are 
replaced with complementary bases. As a result, on-target effects cannot be observed 
anymore, but off-target effects owing to sequences akin to microRNA seed sequences 
persist. In virus transduction assays, MPI-2 cells expressing the SR-A6_C911 shRNA 
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behaved like the parental cells and displayed high GFP expression upon HAdV-
C5_dE1_GFP infection (Fig. 1C), thus confirming the on-target effect of the SR-A6 
shRNA. Preincubation of MPI-2 cells with a blocking antibody against mouse SR-A6 
(ED31) significantly reduced HAdV-C5_dE1_GFP-mediated transgene expression in a 
dose-dependent manner, whereas equivalent amounts of an isotype-matched negative 
control antibody had essentially no effect (Fig. 1D). In contrast, in A549 cells, which 
are epithelial lung carcinoma cells and express CAR, in contrast to MPI-2 cells which 
are devoid of CAR expression [49], preincubation of A549 cells with the ED31 antibody 
did not reduce HAdV-C5_dE1_GFP infection (Fig. 1D). Furthermore, preincubation of 
virus with soluble form of mouse SR-A6 blocked infection in a dose-dependent 
manner, whereas soluble SR-A6 had essentially no effect on virus-mediated GFP 
expression in A549 cells (Fig. 1E). Taken together, these results suggest that SR-A6 is 
required for efficient HAdV-C5 infection of the MPI-2 cells.  
To strengthen this notion, we used two SR-A6-/- MPI cell lines (named M3 and 
M2-4) from fetal liver of SR-A6 knock-out mice. These cells did not express SR-A6 at 
their surface (S1A Fig.) and SR-A6 mRNAs were not detectable in these cells, 
whereas transcripts for SR-B1 were slightly reduced or, in the case of SR-A1 and SR-
B2, actually increased (S1B Fig.). Data in Fig. 1F demonstrate that the HAdV-
C5_dE1_GFP transduction of M3 and M2-4 cells is significantly less efficient than the 
transduction of wild type MPI-2 cells, in agreement with [53]. 
MPI-2 cells have been previously described to respond to HAdV-C5 infection by 
secreting IL-6 and IL-1 [49]. We monitored interferon (IFN) α/β response from wild type 
and SR-A6-deficient MPI cells upon HAdV-C5 infection by titrating media from virus-
infected cells in MEF-Mx2-luc-BKO reporter cell line. This cell line expresses firefly 
luciferase under the control of IFNα/β-inducible Mx2 promoter. As shown in Fig. 1G, 
IFNα/β was released from infected MPI-2 cells, but not from M3 and M2-4 SR-A6 
knockout cells. Similarly, HAdV-C5 did not evoke IFNα/β secretion from MPI-2 cells 
expressing SR-A6 shRNAs, but the virus did induce efficient IFNα/β response from 
cells expressing the control non-targeting SR-A6_C911 shRNA (S1C Fig.). 
Interestingly, although shRNAs against SR-A1 and SR-B1 did not affect HAdV-C5 
gene transduction, these shRNAs reduced the IFNα/β response elicited by HAdV-C5, 
whereas knockdown of SR-B2 had essentially no effect (Fig. 1G).  
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Mouse SR-A6 facilitates binding of HAdV-C5 to cells 
We next compared binding of Alexa-Fluor488-tagged HAdV-C5 to SR-A6+/+ 
MPI-2 cells and the SR-A6-/- M3 and M2-4 cells. Equivalent amounts of the 
fluorophore-tagged virions were added to the SR-A6+/+ and SR-A6-/- cell populations at 
4°C for 1h and after removal of unbound virus, cells were switched to 37°C for 5 min 
before fixation. The samples were imaged by confocal microscopy, and maximum 
projections of confocal stacks were used to score virus particles associated with cells. 
Whereas the SR-A6-positive MPI-2 cells contained many HAdV-C5 particles, only 
occasional virions were associated with M3 and M2-4 SR-A6 knock-out cells (Fig. 2A).  
The virion binding assay was repeated in MPI-2 cells expressing shRNAs 
against various scavenger receptors. Only shRNA directed against SR-A6 significantly 
reduced HAdV-C5 binding, whereas cells expressing shRNAs against SR-A1, SR-B1, 
SR-B2, or the nontargeting shRNA SR-A6_C911 bound virus essentially as efficiently 
as parental MPI-2 cells (S2A and S2B Figs). Soluble SR-A6 was found to be partially 
trimeric, as reported previously [57]. Soluble SR-A6 either suppressed virion binding to 
cells or induced virions to bind to cells in a clustered form (Fig. 2B). These effects 
were strongly dose-dependent. Virion clustering was also observed when purified 
soluble SR-A6 and HAdV-C5 were mixed and analyzed by EM (Fig. 2C). In the 
absence of soluble SR-A6, virus particles were monodispersed, but in the presence of 
SR-A6 large clumps of particles were frequently observed. These clumps most likely 
formed through crosslinking of virus particles by the trimeric fraction of SR-A6. In 
contrast to HAdV-C5, HAdV-B3 bound to MPI-2 cells inefficiently (S2C Fig.), and 
remained monodispersed after incubation with the soluble SR-A6 (S2D Fig.). Taken 
together, these results suggest that SR-A6 is an attachment receptor for HAdV-C5 in 
MPI-2 cells.  
As a further validation, we tested virus colocalization with SR-A6 at the MPI-2 
cell surface by proximity ligation assay (PLA) using Alexa-Fluor488-labeled HAdV-C5, 
rabbit anti-Alexa-Fluor488 antibody and the rat anti-SR-A6 ED31 antibody. PLA 
generates a fluorescent signal if the two antigens are located within a 40 nm distance 
of each other. When HAdV-C5 was bound to MPI-2 cells at 4°C, a strong signal was 
obtained in the PLA assay, whereas cells without virions gave no signal (Fig. 2D). 
Furthermore, when mouse L929 cells, which are low in CAR expression, were 
transfected with a plasmid that directed the synthesis of a bi-cistronic mRNA for 
mouse SR-A6 and, via an internal ribosome entry site, for the red fluorescent protein 
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Tomato, the Tomato-positive cells bound AlexaFluor488-tagged HAdV-C5 particles 
more efficiently than Tomato-negative (and thus SR-A6 negative) cells with the mean 
cell-associated virus number being seven-fold higher in Tomato-positive than Tomato-
negative cells (Fig. 2E). In addition, the mean nuclear GFP signal was about four-fold 
higher in Tomato-positive cells than in Tomato-negative cells after HAdV-
C5_dE1_GFP transduction, whereas the Tomato-positive and -negative cells had 
similar mean nuclear GFP intensities in the control empty vector transfection, and 
these intensities were significantly lower than the GFP signals in the Tomato-positive 
cells in the SR-A6 transfection (Fig. 2F).  
Hexon is the viral ligand for SR-A6 
To probe which virion-associated protein interacts with SR-A6, we first assayed 
whether binding of HAdV-C5 to the MPI-2 cells was mediated by the globular head 
domains (the knobs) of the vertex-associated fiber proteins, i.e. the same structures 
that mediate binding of the virion to the CAR receptor on non-immune cells. To this 
end, we incubated control untreated cells or cells preincubated with purified 
recombinant HAdV-C5 fiber knobs with Atto565-labeled HAdV-C5 at 4°C for 60 min, 
imaged fixed cells by confocal microscopy and used maximum projections of confocal 
stacks to determine the number of cell-associated virus particles. Whereas the fiber 
knobs efficiently suppressed virus binding to the CAR-positive A549 cells, no reduction 
of binding was evident in MPI-2 cells (Fig. 3A). Instead, 5 µg/ml and 1 µg/ml FKs 
produced statistically significant increase of binding to MPI-2 cells (P=0.002 and 
P=0.032, respectively; Kolmogorov-Smirnov test). Of note, tagging of virus particles 
with different fluorophores somewhat affected HAdV-C5 binding to MPI-2 cells: 
whereas Alexa Fluor488, which has an overall negative charge, increased binding in 
comparison to unlabeled viruses (e.g. Fig. 2A and Fig. 3B), Atto565 (no net charge) 
decreased binding (e.g. Fig. 3A and Fig. 3B). 
Ligand binding to SR-A6 and other SRs has been shown to be inhibited by 
polyanionic inhibitors such as poly G [58], thus suggesting that negatively charged 
residues on ligands are involved in the binding. Previously, the flexible HVR-containing 
loops on hexon have been implicated in binding of HAdV-C5 to the scavenger receptor 
SR-A1 [17]. The HVR1 of HAdV-C5 hexon is especially rich in negatively charged 
residues, as compared to HAdV-A31, for example (Fig. 3B). Interestingly, binding of 
HAdV-A31 to MPI-2 cells was inefficient, whereas the SR-A6 negative M2-4 cells 
bound the virus more efficienly than MPI-2 cells (Fig. 3B). 
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We tested the possible involvement of HVR1 in SR-A6 binding by engineering a 
recombinant HAdV-C5 in which the HVR1 was replaced by the HVR1 of HAdV-A31. 
This drastically shortened the HVR1 and removed the negatively charged residues 
(Fig. 3B). The swop was done in HAdV-C5_HVR7* backbone that contained point 
mutations in HVR7, which ablate binding of virus to the coagulation factor X. The swop 
resulted in HAdV-C5_HVR1(A31)/HVR7*. As shown in Fig. 3B and 3C, the point 
mutations in HVR7 did not affect binding of HAdV-C5 to MPI-2 cells, but the HVR1 
swop significantly reduced virion binding, even when the HVR1-swopped virions were 
applied at higher concentration than wild type virions. In contrast, the HVR1 swopped 
virus bound to A549 cells as efficiently as wild type or the HVR7* control virus (Fig. 
3C). The concentrations of HAdV-C5_WT, HAdV-C5_HVR7* and HAdV-
C5_HVR1(A31)/HVR7* were determined by absorbance measurements at 260 nm 
and verified by SDS-PAGE and silver staining (S3A Fig.). Representative images of 
fluorescent virions including HAdV-A31 particles on MPI-2, M2-4 (SR-A6 KO) and 
A549 cells are shown (S3B, C Fig.).  
Similar to wild-type virus, efficient binding of HAdV-C5_HVR7* to MPI cells 
correlated with SR-A6 expression (Fig. 3B). However, the difference of binding HAdV-
A31 or HAdV-C5_HVR1(A31)/HVR7* to the two cell types (MPI-2 and M2-4) was not 
as drastic as the reduction of binding of HAdV-C5_HVR1(A31)/HVR7* compared to 
HAdV-C5_HVR7* on MPI-2 cells. Note however that the HVR1-swapped virus still 
bound slightly more efficiently to MPI-2 cells than to the SR-A6 knock-out M2-4 cells 
(Fig. 3B). The luciferase reporter gene in HAdV-C5_HVR7* and HAdV-
C5_HVR1(A31)/HVR7* was used to probe the virus-mediated gene transduction. In 
agreement with the binding studies, the HVR1 swop reduced transduction by about 
two-fold in comparison to the HVR7* control, whereas the two viruses had similar 
transduction efficiencies in A549 cells (Fig. 3D). Taken together, these results indicate 
that HVR1 of HAdV-C5 hexon contributes to interaction of the virus with SR-A6.  
Mouse SR-A6 promotes efficient HAdV-C5 entry into cells 
To map the SR-A6-mediated entry pathway of HAdV-C5 in more detail, we 
analyzed the efficiency of SR-A6-mediated virus uptake and penetration into the 
cytoplasm. HAdV-C5 penetration into the cytoplasm is critically dependent on 
structural changes in the virion which lead to externalization of the viral membrane lytic 
protein VI [31, 32, 59, 60]. To monitor HAdV-C5 uptake and protein VI exposure in 
MPI-2 cells, Atto565-labeled HAdV-C5 was first bound to cells at 4°C to synchronize 
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virus entry, and cells were then switched to 37°C for 0 min, 10 min or 20 min to allow 
internalization. After internalization, cells were switched back to 4°C and intact cells 
were incubated with the mouse 9C12 anti-hexon antibody to tag surface-associated 
virus. Fixed cells were stained with rabbit anti-protein VI antibody, and the 9C12 and 
anti-protein VI antibodies were detected by Alexa-Fluor680-conjugated anti-mouse 
and Alexa-Fluor488-conjugated anti-rabbit antibodies, respectively. Samples were 
imaged by confocal microscopy and the number of cell surface-associated virus 
particles (virus with both Atto565 and Alexa-Fluor680 signals) and internalized virus 
particles (virus with only Atto565 signal) were determined from maximum projections 
of the confocal stacks. As shown in Fig. 4A, after cold binding and 0 min 
internalization, the majority of virions were identified as surface-associated particles. In 
contrast, after 10 min or 20 min incubation at 37°C, increasing numbers of virions were 
found to be internalized. Only occasional particles were positive for protein VI at 0 min, 
whereas the average protein VI intensity on internalized virus particles was 
significantly higher at the 10 min time point (Fig. 4B, and S4A Fig.), thus indicating that 
the particles had undergone structural changes during early steps of entry that 
enabled externalization of protein VI. The protein VI signal on internalized particles at 
20 min post warming was reduced in comparison to the 10 min time point. Similar 
time-dependent reduction in particle-associated protein VI signal has been observed 
also during entry of HAdV-C5 into non-immune CAR-positive cells, an observation 
which reflects separation of protein VI from particles after penetration of the virus into 
the cytoplasm [31]. 
To assay the efficiency of virion escape into the MPI-2 cell cytoplasm more 
directly, we employed a streptolysin O (SLO)-based penetration assay [61]. Alexa-
Fluor488-conjugated HAdV-C5 particles were bound to cells at 4°C, and subsequently 
internalized at 37°C for 45 min. After internalization, the plasma membrane was 
perforated by SLO to allow access of anti-Alexa-Fluor488 antibodies to the cytoplasm. 
These antibodies tag cell surface-associated and cytoplasmic virus particles, but 
particles in endosomes are inaccessible to the antibodies. The number of virus 
particles at the cell surface was estimated from parallel samples stained with anti-
Alexa-Fluor488 antibodies without SLO permeabilization. After fixation, viruses tagged 
with the anti-Alexa-Fluor488 antibodies were scored by staining with secondary Alexa-
Fluor594-conjugated antibodies. Samples were imaged by confocal microscopy and 
the number of virus particles positive or negative for the anti-Alexa-Fluor488 
antibodies were scored from maximum projections of the confocal stacks. As shown in 
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Fig. 4C, approximately 30% of viruses were antibody-positive after 45 min of 
internalization, but the number of antibody-positive virus particles was variable 
between individual cells, as previously described for virus penetration in HeLa-Ohio 
and A549 cells [61]. The majority of the antibody-positive virions represented 
cytoplasmic particles, since staining of intact cells without SLO permeabilization gave 
only a low number of antibody-positive particles. The endosomes remained intact in 
the assay, since cells infected with the penetration-deficient, endosomal resident 
HAdV-C2_TS1 mutant virus exhibited only a low number of antibody-positive particles. 
Taken together, these results indicate efficient uptake and relatively efficient 
penetration of HAdV-C5 into the MPI-2 cells. 
Incoming cytosolic HAdV-C5 particles traffic to the nucleus, disassemble at the 
nuclear pore complex and import their genome into the nucleus for viral gene 
expression and replication [62]. We used deoxy-5-ethynylcytidine-labeled (EdC) 
HAdV-C5 and copper(I)-catalyzed azide-alkyne cyclo-addition (click) reactions to 
monitor nuclear targeting of viral genomes in MPI-2 cells [63]. EdC-labeled HAdV-C5 
was incubated with MPI-2 cells at 37°C for 30 min, and after washing unbound virus 
away, the cells were further incubated at 37°C for 30 min or 270 min before fixation. 
The viral capsids were visualized by anti-hexon 9C12 primary antibody and Alexa-
Fluor594-conjugated anti-mouse antibodies, and the viral DNA was coupled with 
Alexa-Fluor488-conjugated azide. Representative images from the 30 min and 270 
min time points are shown in Fig. 4D and S4B Fig.. At the early time point, the viral 
DNA was still extensively capsid-associated, but was largely uncoated at the 270 min 
time point, as indicated by the separation of DNA and capsid signals. In the majority of 
cells the uncoated DNA was concentrated over the nuclear area (identified by DAPI 
staining), but, as exemplified by the lower cell in Fig. 4D, occasional cells had 
significant amounts of capsid-free DNA in the cytoplasm, as previously described for 
HeLa cells [63]. 
SR-A6 facilitates infection of MPI-2 cells by HAdV-B35 and HAdV-D26 
We were interested whether mouse SR-A6 is a receptor only for HAdV-C5, or 
whether the protein is a more general entry facilitator for different adenovirus 
serotypes. We compared binding of different adenoviruses to the MPI-2 and the SR-
A6 M2-4 knockout cells. As shown in S2C Fig. and Fig. 3B, HAdV-B3 only inefficiently 
bound to MPI-2 cells and binding of HAdV-A31 did not correlate with SR-A6 
expression. Efficient SR-A6-dependent binding was observed with Alexa-Fluor488-
	13 	
labeled subgroup B virus HAdV-B35 and subgroup D virus HAdV-D26, as well as with 
HAdV-C2 (Fig. 5A). As judged from the mean number of virus particles per cell, HAdV-
C5 binding to MPI-2 cells was approximately 3.6-fold more efficient than that of HAdV-
B35 or HAdV-D26 (S5 Fig.). 
However, no virion binding was detected in the case of HAdV-F41 (data not 
shown). The luciferase reporter gene carried by HAdV-B35 or HAdV-D26 was used to 
assess transduction of wild type and SR-A6 knockout MPI cells by these viruses, in 
comparison to the HAdV-C5-luciferase virus. All three viruses transduced wild type 
MPI-2 cells more efficiently than the M2-4 SR-A6 knockout cells, although the relative 
transduction efficiencies of the three viruses differed (Fig. 5B). Thus, SR-A6 facilitates 
not only HAdV-C5-mediated gene transduction, but also that of HAdV-B35 and HAdV-
D26. However, since HAdV-B35 and HAdV-D26 cell binding was reduced only by 
about 3.6-fold in comparison to HAdV-C5, but the difference in gene transduction was 
about 20-fold or more, the entry steps downstream of cell attachment appear to occur 
with different efficiencies in C5 versus B35 and D26 HAdV infections. 
High surface expression of human SR-A6 facilitates HAdV-C5 infection 
To test whether human SR-A6 as well can act as a facilitator for HAdV-C5 
infection, we first analyzed the ability of human SR-A6 to promote binding of Alexa-
Fluor 488-conjugated HAdV-C5 to the low-CAR murine fibroblast-like L-929 cells. 
Plasmid expressing human SR-A6 from the cytomegalovirus major immediate early 
promoter was transfected into L-929 cells and the transfected cells were identified by 
immunostaining using the anti-human SR-A6 antibody PLK1. As shown in Fig. 6A, 
cells expressing high levels of human SR-A6 at the surface bound the virus more 
efficiently than SR-A6-negative cells. However, we note that the increased virus 
binding was observed only in cells that stained strongly positive for SR-A6, whereas 
weak surface SR-A6 signal did not correlate with increased amounts of cell-associated 
virus (data not shown).  
As previously described [64], high SR-A6 expression induced dendritic surface 
projections and was very toxic to cells. Because of this high toxicity, we turned to a 
different cell line, the human diploid fibroblast-telomerase reverse transcriptase (HDF-
TERT) immortalized cells, for testing the ability of human SR-A6 to boost HAdV-C5-
mediated gene transduction. Compared to e.g. A549 cells, HDF-TERT cells bind 
HAdV-C5 inefficiently (data not shown). Human SR-A6 was expressed in HDF-TERT 
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cells from the same plasmid backbone as mouse SR-A6 in the L-929 cell experiments 
described above. The transfected Tomato-positive cells displayed variable levels of 
SR-A6 at the cell surface, which clearly correlated with the Tomato signal (S6 Fig.). 
The nuclear GFP signal from HAdV-C5_dE1_GFP transduction was used to assay 
infection efficiency in Tomato-positive/transfected and Tomato-negative/non-
transfected cells. As shown in Fig. 6B, Tomato-positive cells in human SR-A6 
transfection exhibited enhanced nuclear GFP levels in comparison to Tomato-negative 
cells, or in comparison to Tomato-positive cells in the control empty vector 
transfection. However, this increase in nuclear GFP signal was rather modest, the 
mean nuclear GFP intensity in Tomato-positive cells was only ~ 1.6-fold higher than 
that in Tomato-negative cells, and the increase was observed only when relatively high 
levels of HAdV-C5_dE1_GFP were used for infection. This was in contrast to what 
was observed for exogenous expression of mouse SR-A6 in L-929 cells (Fig. 2F). 
Therefore, we compared the abilities of mouse and human SR-A6 to boost HAdV-
C5_dE1_GFP in HDF-TERT cells using the same plasmid backbone for expression of 
both proteins. As shown in Fig. 6C, exogenous mouse SR-A6 expression facilitated 
HAdV-C5_dE1_GFP infection more efficiently than human SR-A6, as evidenced by ~ 
8-fold higher mean nuclear GFP intensities in Tomato-positive cells in mouse SR-A6 
transfection than in Tomato-positive cells in human SR-A6 transfection. Thus, although 
human SR-A6 can facilitate HAdV-C5 infection if expressed at high levels at the cell 
surface, human SR-A6 might be a less efficient receptor than the mouse SR-A6. 
 
Discussion 
Macrophages defend an organism against insults, and are key for homeostasis, 
for example by engulfing apoptotic cells. Macrophages take up and present foreign 
antigens, kill pathogens, produce cytokines and chemokines, and coordinate tissue 
repair processes. Here we show that murine alveolar macrophage-like MPI-2 cells can 
be infected by human adenoviruses from several different species. We show that 
HAdV infection in MPI-2 cells requires the scavenger receptor SR-A6, and provide 
evidence that high expression levels of human SR-A6 can boost HAdV-C5 infection as 
well.  
In the past, a number of different molecules have been implicated in HAdV 
attachment to mononuclear phagocytic cells, including MHC class 1, CD80/86, CD209 
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(DC-SIGN) and sialic acid [for a review, see 65]. In vitro and in vivo mouse studies 
have also implicated two other scavenger receptors, the SR-A1 (formerly named SR-A 
or SR-AI/SR-AII for its splice forms) and SR-F1/2 (SREC-1 or Scarf1) in the cell 
uptake of HAdV-C5 [16, 18], and exogenous expression of mouse SR-A1 (splice 
variant II) in CHO cells, which express low levels of CAR, has been shown to increase 
HAdV-C5 mediated gene transduction [16, 17]. The possibility that mouse SR-F1/2 
functions as a HAdV-C5 receptor is based on the observation that hepatocyte 
transduction by intravenously applied HAdV-C5 vector was increased by prior 
treatment of the mice with anti-SR-F1/2 antibody Fab-fragments, the interpretation 
here being that the Fab fragments decreased virus entrapment by SR-F1/F2-positive 
Kupffer cells and liver sinusoidal endothelial cells, thus increasing hepatocyte 
transduction [18]. SR-F1/2 unlikely contributes to HAdV-C5 transduction of MPI-2 
cells, since its mRNA was found to be expressed at higher levels in bone marrow 
derived macrophages (BMM) than MPI-2 cells, and BMM were largely resistant to 
HAdV-C5 [49, 53].  
Here we show that the knockdown of SR-A1 cells did not reduce HAdV-C5 
binding or virus-mediated gene transfer, whereas knockdown of SR-A6 drastically 
affected both binding and gene transduction in MPI-2 cells. This is in agreement with 
experiments using primary alveolar macrophages from SR-A1 knock-out mice which 
upon inoculation with Ad-GFP still expressed as high levels of GFP, as alveolar 
macrophages from wild type B6 animals, yet reduced IL-6 response was observed 
from the SR-A1 knock-out cells [53]. The apparent discrepancy between our study and 
the previous SR-A1 studies could stem from many factors, such as the cell surface 
expression levels, or expression of splice variants of SR-A1. Note that only the splice 
variant II of SR-A1 has been shown to facilitate HAdV-C5 entry. Intriguingly, although 
our results did not suggest a role for SR-A1 in HAdV-C5 binding or virus-mediated 
gene transfer in MPI-2 cells, IFNα/β response to virus was quenched upon SR-A1 (or 
SR-B1) knockdown, albeit not as drastically as upon SR-A6 knockdown. This suggests 
that SR other than SR-A6 could have roles in infection distinct from virion binding. 
Furthermore, as exemplified by HAdV-A31, surface receptors other than SR-A6 can 
mediate attachment of an adenovirus particle to macrophages, since binding of HAdV-
A31 to MPI-2 cells did not correlate with SR-A6 expression. HAdV-A31 binding and 
transduction of macrophages were, however, clearly independent of SR-A6, indicated 
by the overall lower binding efficiency of HAdV-A31 on MPI-2 cells compared to HAdV-
C5, even at 5-fold higher dose of HAdV-A31 than HAdV-C5. 
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HAdV-C5 infection of MPI-2 cells occurs through virion binding to the SR-A6 
scavenger receptor, and leads to limited uncoating exposing the membrane lytic virion 
protein VI. Protein VI exposure enables virion penetration of an endosomal membrane 
and the transport of partly uncoated virions to the nuclear membrane, where the 
delivery of the viral DNA genome into the nucleus occurs. All these steps occur in the 
alveolar macrophage-like cells with high efficiency, albeit with significant cell-to-cell 
variation. The molecular basis of this variation is unknown at present. However, overall 
the endosomal escape was only slightly reduced compared to epithelial cells [61]. 
Epithelial cells engage the adenovirus particles by a sequential binding to CAR and 
integrin receptors, and exert mechanical cues to trigger the initial steps of uncoating 
[22, 24, 31, 32, 59-61, 66-68]. Whether integrins are also involved in entry of HAdV-C5 
into MPI-2 cells is a subject for future studies. 
The relatively efficient virus penetration into the cytoplasm of the MPI-2 cells not 
only enabled delivery of the viral genome into the nucleus for virus-mediated gene 
transduction, but also exposed the virus to cytoplasmic innate immune sensors, such 
as the cytoplasmic DNA sensor cyclic GMP-AMP synthase (cGAS) [53]. As previously 
described for HeLa cell infection [63], we observed that a fraction of HAdV-C5-infected 
MPI-2 cells displayed significant amounts of capsid-free virus genomes in the 
cytoplasm. This cytoplasmic DNA apparently plays a key role in innate immune 
sensing of incoming HAdV-C5 in MPI-2 cells, since HAdV-C5 entry into these cells 
triggers activation of the mitogen activated protein kinase p38, activation of the 
transcription factors IRF-3 and NF-κB, as well as secretion of interferon α/β, IL-6 and 
IL-1α, and these responses are blunted when cGAS is knocked-down in the cells [Fig. 
1G, and 53]. Collectively, our data support the ‘macrophage enigma’, where 
macrophages enable pathogens to replicate, and also serve as hubs to execute 
pathogen destruction and coordinate host defense [3].  
SR-A6 is a trimeric disulfide-bonded, single-pass type II integral membrane 
protein, which belongs to the class A scavenger receptors [reviewed in 12, 58]. The 
extracellular domain of SR-A6 is composed of a collagenous triple helix structure and 
a carboxy-terminal type A scavenger receptor cysteine-rich domain. By using the 
mouse alveolar macrophage-like cell line MPI-2, we found several lines of evidence in 
support of SR-A6 being a receptor for HAdV-C5. First, knock-out of SR-A6 reduced 
binding of HAdV-C5 to MPI-2 cells, as well as virus-mediated gene transfer. Second, 
reduced HAdV-C5-mediated gene transduction was observed also when cells were 
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pre-incubated with an anti-SR-A6 antibody. Third, a soluble form of mouse SR-A6 
interfered with HAdV-C5 binding to MPI-2 cells and virus-mediated gene transfer, as 
well as induced virus clustering in an in vitro assay composed of purified soluble SR-
A6 and HAdV-C5. Fourth, colocalization between surface-bound HAdV-C5 and SR-A6 
on MPI-2 cells was observed in a proximity ligation assay, and, fifth, exogenous 
expression of mouse SR-A6 in the L-929 mouse cell line, which express low levels of 
CAR [69], increased binding of HAdV-C5 to these cells, as well as the virus-mediated 
gene transduction. Thus, mouse SR-A6 fulfills a set of stringent criteria for being a 
receptor of HAdV-C5. Its ability and to a lesser extent the ability of human SR-A6 to 
mediate binding and transduction with HAdV-C2, C5, B35 and D26 has implications for 
the transduction of human hematopoietic cells with B35, and human vaccinations with 
C5 and D26 [70-72]. Although the clustering of HAdV-C5 by soluble SR-A6 in the in 
vitro assay suggests that SR-A6 directly binds to this virus, the interaction is most 
likely of rather low affinity, similar to HAdV-B3 avidity binding to CD46 [29]. Weak 
binding of adenovirus to soluble SR-A6 is consistent with the notion that the trimeric 
form of SR-A6 is required for efficient ligand attachment [57].  
Fiber knobs mediate interaction of HAdV-C5 with CAR, but binding of the virus 
to MPI-2 cells was not inhibited by soluble fiber knobs. In contrast, our results point 
towards hexon, and especially the HVR1 of hexon, being involved in attachment of 
HAdV-C5 to MPI-2 cells. When the long, negatively-charged HVR1 of HAdV-C5 was 
replaced by the short HVR1 of HAdV-A31, which lacks acidic residues, binding and 
gene transduction of the swop-virus in MPI-2 cells, but not in the CAR-positive A549 
cells, was reduced in comparison to HVR1 wild type HAdV-C5. HVR1 is exposed on 
the surface near the rim of the cup formed in the hexon trimer (S7A Fig.), and is thus 
available for receptor interaction. In general, negatively-charged residues on SR-A6 
and SR-A1 ligands have been implicated in mediating the binding to these SRs [17]. 
HAdV-A31, HAdV-B3 and HAdV-F41, which have short HVR1 and/or lack negatively-
charged residue clusters in HVR1 (S7B Fig.) did not bind to MPI-2 cells efficiently or 
the binding did not correlate with SR-A6 expression, as shown for HAdV-A31. HAdV-
B35 hexon has a cluster of acidic residues in HVR1, and binding of this virus to MPI 
cells did correlate with SR-A6 expression. However, although HAdV-D26 interaction 
with MPI cells also correlated with SR-A6 expression, a prominent acidic cluster in the 
D26 hexon HVR1 is missing (S7B Fig.). Furthermore, although the hexon HVR1(A31) 
swop-HAdV-C5 exhibited reduced MPI cell binding, the mean cell-associated virus 
count in the binding assays was only reduced by about three-fold in comparison to 
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HVR1 wild type virus. Thus, other surface-exposed hexon regions and/or other capsid-
associated proteins may also contribute to the binding.  
Like other scavenger receptors, SR-A6 binds to a number of ligands and/or 
exist in different complexes at the cell surface [11]. SR-A6 has been implicated to play 
a significant role in various host-pathogen settings in both mice and humans. For 
example, SR-A6-knockout mice show impaired clearance of bacteria from lungs and 
increased mortality upon Streptococcus pneumoniae infection [73]. In contrast, SR-A6 
apparently suppresses protective early inflammatory responses to influenza virus and 
the SR-A6-knockout mice exhibit lower mortality upon influenza pneumonia than wild-
type mice [74]. Furthermore, SR-A6 has been shown to modulate signaling from other 
pattern recognition receptors. For example, SR-A6 co-operates with Toll-like receptor 
2 and CD14 to initiate innate immune responses to the Mycobacterium tuberculosis 
cell wall glycolipid trehalose dimycolate in mice [75], and SR-A6 knockout modulates 
proinflammatory responses to several different Toll-like receptor agonists in mouse 
splenic dendritic cells [76]. In addition, SR-A6 binds to the muramyl dipeptide (MDP), a 
cell wall component of both Gram-negative and Gram-positive bacteria, and knockout 
of SR-A6 reduces NOD2 (nucleotide-binding oligomerization domain 2)-mediated 
responses to the MDP, as well as NALP3 (NACHT domain-, leucine-rich repeat-, and 
pyrin-domain containing protein 3) inflammasome-dependent secretion of mature IL-1β 
upon challenge of mice with inactivated Neisseria meningitides [77]. SR-A6 is 
expressed on human lung macrophages and incubation of these cells with an anti-SR-
A6 antibody reduced binding of latex beads, TiO2, heat-inactivated E. coli or 
Staphylococcus aureus to these cells, thus suggesting that SR-A6 has a major role in 
clearance of non-opsonized particles and bacteria by human lung macrophages [73]. 
Recent studies have also identified human SR-A6 as a receptor for herpes simplex 
type 1 and vaccinia virus [15, 78].  
High expression levels of human SR-A6 upon transient transfection gave rise to 
HAdV-C5 binding and infection, albeit at low efficiency, whereas expression of mouse 
SR-A6 gave higher HAdV-C5 binding and infection levels. The human SR-A6 appears 
to be a less efficient receptor for HAdV-C5 than the mouse SR-A6. Possibly this is 
related to the differences in amino acids in the extracellular domains of human and 
murine SR-A6 [58]. Interestingly, polymorphism in the SR-A6 gene has been linked to 
increased susceptibility to pulmonary tuberculosis in humans [79, 80]. When 
transcriptional responses in primary monocytes from individuals of African or 
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European origins were compared, SR-A6 was found to be among the genes displaying 
largest population differences upon stimulation with seasonal influenza A virus [81]. A 
function for mouse SR-A6 as a receptor for HAdV-C5 is consistent with previous 
observations that the mouse spleen marginal zone macrophages sequester HAdV-C5 
after intravascular administration of the virion [44, 82, 83], and that SR-A6-positive 
lung macrophages trap HAdV-C5 in the respiratory tract [47, 48]. Overall, the study 
here identifies the scavenger receptor SR-A6 as an important transporter of HAdV into 
murine lung macrophages. This finding will enhance the interpretation of preclinical 
models in gene therapy and vector research, a field which is driven by the use of 
adenoviruses.  
 
 
Materials and Methods 
Cells 
The wild type (line 2) and SR-A6 deficient (lines M2-4 and M3) MPI (Max-
Planck-Institute) alveolar macrophage-like cells were originally generated from fetal 
liver of wild type and SR-A6-/- C57/BL6 mice [49, 53]. The cells were grown in RPMI 
1640 supplemented with 10% heat-inactivated fetal calf serum (FCS; Gibco/Thermo 
Fisher Scientific) and 10 ng/mL murine recombinant GM-CSF (Miltenyi Biotec). Two 
different clones of human lung epithelial carcinoma A549 cells were used in the study: 
our old laboratory A549 clone and A549 from American Type Culture Collection 
(ATCC). Highly-polymorphic short tandem repeat loci profiling indicated that the two 
clones were ~95.1% similar. Human embryonic retinoblast (HER) 911 cells, which 
contain base pairs 79 to 5789 of the HAdV-C5 genome, were from American Type 
Culture Collection (ATCC) and maintained in DMEM supplemented with 7.5% FCS 
and 1% nonessential amino acids. Murine subcutaneous areolar and adipose tissue L-
929 cells from ATCC, which express low levels of CAR, as well as the immortalized 
human diploid fibroblast HDF-TERT cells expressing the catalytic subunit of 
telomerase (kindly provided by Patrick Hearing and Kathleen Rundell) [84], were 
maintained in DMEM supplemented with 10% FCS and 1% nonessential amino acids. 
Mouse embryo fibroblasts (MEF) were obtained from Mx2-Luc IFN-β deficient (BKO), 
13.5 days old Balb/c mouse embryos, as previously described for the MBa10 and 
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MBa5 MEF [85]. For immortalization, primary cells were plated on 6-well cell culture 
dishes (105 cells), and infected with two self-inactivating lentiviral vectors encoding for 
c-myc and E7 overnight in the presence of 8 µg/ml polybrene. The expression of the 
recombinant genes was driven by the SV40 promoter [86]. The following day infection 
medium was aspirated, and the cells were expanded with the above mentioned culture 
medium until they showed robust proliferation (doubling time ~1d) and the 
corresponding mock transduced primary cells stopped proliferating. The immortalized 
Mx2 luc BKO MEF, which express firefly luciferase under the interferon-inducible Mx2 
promoter, were maintained in A549 base medium supplemented with 0.1 mM β-
mercaptoethanol. HEK-293 cells producing recombinant, soluble mSR-A6 were a kind 
gift from Andrij Holian (University of Montana, USA) and maintained in A549 base 
medium with 250 µg/ml G418 and 1 µg/ml puromycin.  
Viruses 
HAdV-C2 and HAdV-C5 were grown in A549 cells, whereas HAdV-A31 (kindly 
provided by Anja Ehrhardt, University of Witten/Herdecke, Germany) was grown in 
HeLa (ATCC) cells. The viruses were isolated, and labeled with Alexa-Fluor488 
(Thermo Fisher Scientific) or Atto565 (Sigma-Aldrich) as described [87-89]. The 
replication-deficient HAdV-C5_dE1_GFP, an E1/E3 deletion mutant virus containing 
the enhanced green fluorescent protein (GFP) gene in the E1 region under the control 
of cytomegalovirus major immediate early promoter [90, 91] was grown in HER-911 
cells. Notably, GFP localizes to the nucleus owing to a weak nuclear localization signal 
[92]. The replication-deficient HAdV-C5_HVR7* and HAdV-C5_HVR1(A31)/HVR7* 
with mutations in the hexon gene are derived from the AdEasy system (Agilent). The 
mutations were introduced in a 2-step process. First, the entire hexon gene was 
replaced by a kanamycin resistance gene flanked by two unique XbaI restriction sites 
using homologous recombination. In the second step, the kanamycin gene was 
removed by XbaI digestion. The mutated hexon gene was recombined with the 
linearized and purified pAdEasy fragment in BJ5183 [93], and selection for 
recircularization was performed using ampicillin. The negatively charged HVR1 of the 
hexon from HAdV5 was thus replaced by the short HVR1 from HAdV31 
(DEAATALEINLEEEDDDNEDEVDEQAEQQ was changed to LTTNNGN). The 
modifications in HVR7 contained several point mutations which have been shown to 
ablate factor X binding (INTETL was changed to GNNSTY) [94]. The modified 
pAdEasy constructs were recombined with the plasmid 
pShuttle_CMV_luci_IRES_GFP (encoding firefly luciferase followed by a IRES and 
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sfGFP). The viruses were grown in HEK-293 cells. All viruses were purified by two 
rounds of CsCl banding, dialyzed against 10 mM Tris pH 8.1, 150 mM NaCl and 1 mM 
MgCl2 and stored at -80°C in 10%(v/v) glycerol. Absorbance measurements at 260 nm 
or protein concentration were used for determination of number of virus particles per 
ml [95]. Alexa-Fluor488-labeled HAdV-D26 and HAdV-B35 vectors carrying the firefly 
luciferase gene were kindly provided by Jerome Custers and Dragomira Majhen 
(Janssen Pharmaceutical Companies of Johnson & Johnson, Netherlands).  
shRNA-mediated knockdown of mouse scavenger receptors 
Plasmids pENTR/pTER+(431-1) and pQCXIN X2 DEST (w310-1) were a gift 
from Eric Campeau and obtained from Addgene (Addgene plasmids #17453 and  
#17399, respectively) [96]. Oligonucleotides used for cloning of the shRNA constructs 
targeting mouse scavenger receptors are listed in S1 Table. The oligonucleotide pairs 
were annealed and cloned via their BglII-HindIII-overhangs into the entry vector 
pENTR/pTER+(431-1), and recombined into the destination vector pCQXIN X2 DEST 
(w310-1) using Gateway cloning with LR clonase. Plasmids were verified by 
sequencing. VSV-G-pseudo-typed MLV retroviruses were generated according to 
standard procedure in HEK 293T cells. MPI-2 cells were infected with the retroviral 
vectors and after 48h treated with 0.5 mg/ml G418 to produce a polyclonal population 
of shRNA-expressing cells. A monoclonal cell population was generated for shSR-A6 
cells by limiting dilution cloning. 
Viral transduction of MPI cells 
Cells were seeded at a density of 30000 per well in a 96-well imaging plate and 
triplicate wells were infected the following day with three two-fold dilutions of HAdV-
C5_dE1_GFP (300 ng,  150 ng  or 75 ng virus per well) for 20h at 37°C in MPI-2 
growth medium. The samples were fixed with 3% paraformaldehyde in phosphate-
buffered saline (PBS) for 20 min at room temperature (RT), quenched for 10 min with 
25 mM ammonium chloride in PBS and stained with a DAPI solution (1 µg/ml 4’,6-
diamidino-2-phenylindole and 0.1% Tween-20 in PBS). The plates were imaged on a 
Molecular Devices ImageXpress Micro XL high throughput microscope at a 
magnification of 10X and 3x3 sites per well. The infection was scored by measuring 
GFP-intensity over DAPI mask using a custom-programmed MatLab (The Mathworks) 
routine. The MatLab routines used in this study are available upon request. 
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For analyzing virus transduction efficiency by luciferase-assay, wild type MPI-2 
or the SR-A6 knockout M2-4 cells were seeded at a density of 80000 cells per well in a 
96-well plate and duplicate wells were infected the following day with HAdV-C5, HAdV-
D26 or HAdV-B35 vectors carrying the firefly luciferase gene. At 20.5 h post infection 
(pi), cells were washed once with PBS, and cell extracts were prepared using 40 µl of 
Promega cell culture lysis reagent (# E153A) per well. Twenty-five µl of cell extracts 
were mixed with 35 µl of Promega Luciferase Assay Substrate (# E151A) and the 
luciferase activity in the cell extracts was recorded using Tecan Infinite® 200 (Tecan, 
Switzerland). 
Virus binding assay in MPI cells 
Cells were seeded at a density of 105 or 2×105 on coverslips in a 24-well plate 
format and grown for two days or one day, respectively. Alexa-Fluor488-labeled 
HAdVs (about 130 ng of HAdV-C5, or 1.8 × 109 or 5.6 × 108 virus particles in the case 
of HAdV-D26 and HAdV-B35, respectively) were added to cells at 4°C for 60 min in 
RPMI 1640 medium (without NaHCO3) supplemented with 0.2% bovine serum albumin 
(BSA; Sigma-Aldrich/Merck), 20 mM HEPES, and penicillin-streptomycin (RPMI-BSA 
medium). In the case of HAdV-A31 the virus was labeled with Atto565, whereas 
unlabeled virions were used in HAdV-C5_HVR1(A31)/HVR7* assays. Unbound 
particles were washed away and cells were switched to 37°C for 5 min. The cells were 
fixed and DAPI-stained as described above. Immunostaining with mouse anti-hexon 
9C12 antibody [97], and secondary anti-mouse Alexa-Fluor488-conjugated antibodies 
were used to detect unlabeled viruses. Alexa Fluor647 NHS Ester (A20006, Thermo 
Fisher Scientific: 0.5 µg/ml in PBS for 10 min) was used for staining of the cell area. 
Imaging was carried out with a Leica SP5 confocal laser scanning microscope using 
63x magnification (oil immersion, numerical aperture 1.4) and zoom factor 2. Stacks 
were recorded at 0.5 µm intervals using 4× frame averaging, and a minimum of 50 
cells per condition were imaged. A custom-programmed MatLab routine or a 
CellProfiler (http://cellprofiler.org) pipeline was used to determine the number of cell-
associated virus particles from maximum projections of confocal stacks, or, if the 
number of cell-associated virus particles was too high for accurate single particle 
segmentation, the virus binding efficiency was estimated using a CellProfiler pipeline 
to determine the percentage of cell surface covered by virus particles. The resulting 
data were sorted using KNIME Analytics Platform (https://www.knime.org/knime-
analytics-platform). GraphPad Prism (GraphPad Software, Inc. La Jolla) was used for 
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producing scatter plots and statistical analyses. Representative images shown in 
figures are maximum projections of confocal stacks and images were processed with 
Fiji [98] applying the same changes in brightness and contrast to all image groups in 
the series. 
Blocking assays and soluble mouse SR-A6 
For antibody-mediated blocking, cells were pre-incubated with rat-anti-mSR-A6 
(clone ED31, Bio-Rad Laboratories, 1 mg/ml) at 1:25, 1:75 and 1:250 dilutions in 75 µl 
RPMI-BSA at 4°C for 30 min. Then, the above described virus transduction protocol 
was followed. Isotype-matched rat IgG1 negative control antibody was used as a 
control. The entire extracellular part of mouse SR-A6 (mSR-A6 soluble) was purified 
from transfected HEK-293 cells as described [57]. As judged from SDS-PAGE 
analyses, the protein was largely monomeric and contained a small amount of trimers 
(15-20%) in non-reducing SDS-PAGE analyses, as described earlier [57]. For soluble 
mSR-A6-mediated blocking, Alexa-Fluor488-labeled HAdV-C5 (about 800 ng) or 
HAdV-C5_dE1_GFP (about 300 ng) was pre-incubated with three different 
concentrations of the soluble mSR-A6 (about 125 ng, 250 ng or 500 ng) at room 
temperature for 15 min in 20 µl RPMI-BSA supplemented with 0.5 mM CaCl2 and 0.6 
mM MgCl2, added to the cells in MPI growth medium and then the above described 
virus transduction and virus binding assay protocols using cells seeded on a 96-well 
plate were followed. For fiber knob (FK) experiments, MPI-2 and A549 cells grown on 
coverslips in 24-well plate (~1.6×105 cells per well) were first preincubated for 30 min 
on ice with 8 ng/ml, 40 ng/ml, 200 ng/ml, 1 µg/ml or 5 µg/ml of soluble HAdV-C5 FKs 
[29] in RPMI-BSA medium, after which 1.6 µg of Atto565-conjugated HAdV-C5 was 
added, and incubation was continued for 45 min on ice. Unbound virus was washed 
away and cells were fixed and processed as described above for virus binding assay. 
Cell-based IFN-α/β measurement 
MEF Mx2 luc BKO were seeded on 96-well plates the previous day at a density 
of 35000 cells per well. Medium was discarded and standards were applied in 
duplicates in 100 µl starting from 200 U/mL of recombinant mu-IFNβ (Sigma-Aldrich, 
#I9032) in seven two-fold dilutions. Fifty µl cell-free supernatants from infection 
experiments of MPI cells (see above) were combined with 50 µl fresh MEF-medium in 
duplicates and incubated for 20 h at 37°C. Then, medium was discarded and cells 
lysed with 40 µl of Cell Culture Lysis Reagent (Promega), incubated for 7 min on a 
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rocker plate and 20 µl of each lysate was transferred to a LUMITRAC plate (Greiner). 
Forty µl Luciferase Assay Reagent (Promega, #E1500) was injected into each well on 
a TECAN plate reader with injection unit. After injection, the plate was shaken for two 
seconds and luminescence signal was integrated for 20 seconds. Values were 
background-subtracted, averaged, converted with an IFN-αβ calibration curve and 
plotted with GraphPad Prism. 
Flow cytometry 
Cells were lifted by brief PBS/1.5 mM EDTA treatment, counted and divided into 
aliquots of 100000 cells each. Live cells were surface-stained with 1:10 diluted FITC-
conjugated rat-anti-mSR-A6 (Bio-Rad Laboratories, #MCA1849FT, 0.1 mg/ml) on ice 
in PBS and co-incubated with propidium iodide according to the manufacturer’s 
recommendations (Molecular Probes). Data were collected on a FACS Canto flow 
cytometer (BD Biosciences) maintained by the Flow Cytometry Facility at the 
University of Zurich, and data were analyzed using FlowJo (TreeStar). Cells were 
gated on live singlets indicated by low propidium iodide incorporation and gating on 
FSC-H/FSC-A. 
qRT-PCR 
Total cellular mRNA was isolated using a column-based Nucleospin II RNA Kit 
(Macherey-Nagel, #740995.50) as instructed by the manufacturer, followed by an 
extra DNaseI digest (Ambion, #AM1906). For qRT-PCR, a two-step protocol was 
employed. First, cDNA was synthesized from 150 ng total RNA in a volume of 20 µL 
using the Transcriptor First Strand cDNA Synthesis Kit (Roche, #05091284001) with 
an Oligo(dT)18 primer. Second, amplification was carried out in a total volume of 20 µl 
by using the MesaGreen SYBR Green Master Mix (Eurogentec, #RT-SY2x-03+WOU) 
in an ABIPrism®7900HT and pipetting by a TECAN Genesis robot. Oligonucleotides 
used are listed in S2 Table. Cycles consisted of an initial denaturation at 95°C for 5 
min, forty cycles at 95°C for 15 sec and 60°C for 1 min, and a final dissociation step. 
All determinations were performed in technical triplicates. Controls lacking template 
and reverse transcriptase were run with every assay and had cycle thresholds (CT) 
which were significantly higher than experimental samples or undetermined. The 
relative abundance of each mRNA was calculated by the ΔΔCt method normalizing to 
three mouse housekeeping genes (GAPDH, TBP and EEF1A1). 
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Proximity ligation assay 
MPI-2 cells were seeded on coverslips at 200000 cells per well in a 24-well 
plate. Alexa-Fluor488-conjugated HAdV-C5 (70 ng) was added to cells in RPMI-BSA 
medium at +4°C for 60 min. Unbound viruses were removed by washing with cold 
RPMI-BSA medium, followed by fixation with 3% paraformaldehyde in PBS. Cells were 
then stained with rabbit anti-Alexa-Fluor488 antibody (A-11094, Thermo Fisher 
Scientific) and with rat anti-mSR-A6 ED-31 antibody (MBS215280, MyBioSource) for 
one hour at +4°C in a humidified chamber. Anti-mouse-MINUS (cross-reactive to rat 
antibodies) and anti-rabbit-PLUS PLA probes (conjugated with oligonucleotides) were 
added, and hybridization, ligation, amplification and detection steps were performed 
according to the manufacturer’s instructions (PLA Duolink, Olink) to generate an 
amplified fluorescent signal in areas where the antigens recognized by the two primary 
antibodies reside within less than 40 nm distance of each other. Fluorescent PLA 
signals were imaged using confocal fluorescence microscopy and the shown images 
represent maximum projections of confocal stacks. 
Expression of murine SR-A6 in L-929 cells 
Murine SR-A6 was expressed from a cytomegalovirus major immediate early 
promoter as a bi-cistronic mRNA together with an internal ribosome entry site followed 
by tandem-dimer Tomato (the pCMVspit-vector construct was a kind gift from Peter 
Nielsen, Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg Germany) 
[53]. The cDNA of murine SR-A6 contains both of the 5’ ATG codons [99]. The plasmid 
was transfected into L-929 cells by the Neon electroporation device (Thermo Fisher 
Scientific), using 5 µg of plasmid per 106 cells and settings 1400 V, 30 ms, and 1 
pulse. Empty vector was used as a control. After electroporation, cells were diluted 
into L-929 growth medium and plated on coverslips in 24-well plates for virus binding 
studies or on 96-well imaging plates for virus transduction studies. Twenty-four hours 
post transfection, virus binding was analyzed with Alexa-Fluor488-conjugated virus (~ 
3 µg virus/well), and virus transduction was analyzed using HAdV-C5_dE1_GFP (17.5 
or 8.8 ng virus/well) as described above, except that images from the virus 
transduction assay were analyzed by CellProfiler and the resulting data were sorted 
using the KNIME Analytics Platform. Since Tomato signals had somewhat different 
overall intensities in SR-A6 and empty vector-transfected cells, the threshold for 
Tomato-positive and Tomato-negative cells was adjusted for each sample so that 
about 10% of cells were scored as Tomato-positive, which roughly corresponded to 
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the overall transfection efficiency. Mean nuclear GFP intensities were calculated for 
Tomato-positive and –negative cells and these intensities were used to score the 
infection. The CellProfiler and KNIME pipelines used will be made available upon 
request. GraphPad Prism was used for producing the scatter blots or Tukey box plots, 
as well as for statistical analyses. 
Expression of human SR-A6 in L-929 and HDF-TERT cells 
Human SR-A6 cDNA was a kind gift from Dr. Peter Nielsen. It was expressed in 
L-929 cells from a modified pcDNA3.1-vector (ThermoFisher Scientific) in which the 
endogenous cytomegalovirus promoter was replaced by the cytomegalovirus 
immediate early promoter plus intron A (the plasmid was kindly provided by Jovan 
Pavlovic, University of Zurich). The cDNA of human SR-A6 starts from the second 5’ 
ATG codon, i.e. the expected main codon for the initiator methionine [99]. A cDNA that 
retained both of the 5’ ATG codons was also tested, but no improvement for HAdV-C5 
binding to cells or virus-mediated gene transduction was observed with this variant 
(data not shown). The plasmid was transfected into L-929 cells by Neon transfection 
as described above, except that 2.5 µg of plasmid was used per 106 cells. Alexa-Fluor 
488-conjugated HAdV-C5 (~ 5 µg virus/well) was used for analysis of virus binding to 
cells as described above. Transfected cells were identified by staining for surface SR-
A6 using anti-human SR-A6 antibody PLK1 (HM2208, Hycult Biotech) and Alexa-Fluor 
594-conjugated secondary anti-mouse antibodies as described [61].  The expression 
vector pCMVspit was used for expression of human SR-A6 in HDF-TERT cells. The 
vector was introduced into these cells by Neon transfection using 2 µg of plasmid per 
5×105cells and settings 1650 V, 10 ms and 3 pulses. Thirty-six hours post transfection 
cells were infected with HAdV-C5_dE1_GFP (190 or 95 ng virus/well) and virus 
infection was scored after 30 h as described above for mouse SR-A6-expressing L929 
cells. In Fig. 5B, the highest nuclear “Tomato” signal from non-transfected cells was 
used as a threshold for identification of Tomato-positive cells, and, accordingly, 15 % 
and 6 % of empty vector or SR-A6 transfected cells, respectively, were identified as 
Tomato-positive cells. In Fig. 5C, the Tomato signals in human SR-A6 transfection 
were about two-fold higher than in the mouse SR-A6 transfection and the threshold for 
Tomato-positive and Tomato-negative cells was adjusted for each sample so that 
about 10% of cells were scored as Tomato-positive. 
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Endocytosis and protein VI exposure assays 
MPI-2 cells were seeded on cover slips at 200000 cells per well in a 24-well 
plate the previous day HAdV-C5 (1.4 µg/well), labeled with Atto565 was added to cells 
in RPMI-BSA medium for 60 min on ice. Cells were then washed with cold RPMI-BSA 
and transferred to 37°C for 0, 10 and 20 min. Afterwards, intact cells were incubated 
with 9C12 anti-hexon antibody in RPMI-0.2% BSA at 0°C for 1h to tag surface virus as 
described [61]. The 9C12 antibody, developed by Laurence Fayadat and Wiebe Olijve, 
was obtained from Developmental Studies Hybridoma Bank developed under the 
auspices of the National Institute of Child Health and Human Development. Cells were 
then fixed with 3% paraformaldehyde in PBS and stained with affinity-purified anti-VI 
antibodies [31] and Alexa-Fluor680 anti-mouse and Alexa-Fluor488 anti-rabbit and 
DAPI as described in [61]. Imaging was performed with a Leica SP5 confocal 
microscope as described in [61]. Maximum projections of confocal stacks were 
analyzed by a custom-programmed MATLAB routine to score the number of cell 
surface-associated virus (virus with both Atto565 and Alexa-Fluor680 signals) and 
internalized virus (virus with only Atto565 signal) per cell, as well as protein VI signal 
on internalized virus particles. GraphPad Prism was used for producing scatter plots 
and statistical analyses. Representative images shown in figures are maximum 
projections of the confocal stacks, and the images were processed with Fiji applying 
the same changes in brightness and contrast to all image groups in the series. 
Streptolysin O assay to detect cytosolic virions 
MPI-2 cells were seeded on coverslips at 80000 cells per well in 24-well plates 
and grown over two nights. Alexa-Fluor488-labeled HAdV-C5 virus (0.3 µg / well) was 
bound to cells in RPMI-BSA medium at +4°C for 60 min. Unbound virus was removed 
by washing with cold RPMI-BSA and cells were shifted to 37°C for 45 min to allow 
virus internalization.  During the last 15 min of internalization, cells were treated with 
methyl-β-cyclodextrin/cholesterol mix (Sigma C4951: final concentration 480µM) to 
improve binding of streptolysin O (SLO) to cells. SLO permeabilization and scoring of 
cytoplasmic virus particles by rabbit anti-Alexa-Fluor488 antibody was done as 
previously described [61]. 
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Analysis of incoming virion genomes 
EdC-labeled HAdV-C5 was produced as described in [63]. MPI-2 cells were 
seeded on coverslips at 80000 cells per well in 24-well plate and grown over two 
nights. Virus (0.3 µg / well) was bound to cells for 30 min at 37°C in DMEM 
supplemented with 0.2% BSA, unbound virus was washed away and incubation was 
continued for further 30 min or 270 min in MPI-2 growth medium at 37°C. Cells were 
then fixed with 3% paraformaldehyde in PBS, stained with the anti-hexon 9C12 
antibody and Alexa-Fluor594-conjugated anti-mouse antibodies as described in [61], 
and subsequently the copper(I)-catalyzed azide alkyne cycloaddition (Click) reaction 
with Alexa-Fluor488-azide was carried out as described in [63]. Nuclei were stained 
with DAPI and samples were imaged by Leica SP8 upright confocal laser scanning 
microscope using a 63 × objective (oil immersion; numerical aperture 1.4) and zoom 
factor 4.09. Excitations were at 405 nm (DAPI), 488 nm (viral DNA) and 552 nm 
(virions). Stacks were recorded at 0.5 µm intervals using 4 × frame averaging for DNA 
and virus channels, and sequential acquisition for the individual channels. 
Representative images shown in figures are maximum projections of the whole stacks 
(30 min time point) or the middle thirteen sections of the cells (270 min time point), and 
the images were processed with Fiji applying the same changes in brightness and 
contrast to all image groups in the series. 
Electron microscopy 
HAdV-C5 and HAdV-B3 virions (about 300 ng) were incubated with soluble 
murine SR-A6 (about 200 ng) in 20 µl of 20 mM Tris-HCl pH 7.4 buffer containing 150 
mM NaCl, 1 mM MgCl2 and 0.9 mM CaCl2 for 20 min at room temperature, spotted on 
carbon-coated glow-discharged copper-palladium grids, and stained with 2% uranyl 
acetate for a few seconds [100]. Digital micrographs were collected with a Gatan Orius 
SC1000 CCD camera on a Philips CM100 electron microscope operating at 100 keV 
with a nominal magnification of 46,000×.  
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Figures and figure legends 
Fig. 1: SR-A6 is required for HAdV-C5 infection of murine alveolar macrophage-
like MPI-2 cells 
A) Transduction assay with HAdV-C5_dE1_GFP in MPI-2 cells expressing shRNAs 
against the scavenger receptors SR-A1, SR-A6, SR-B1 and SR-B2. Three different 
input amounts of HAdV-C5_dE1_GFP (~9765 – 39000 virus particles per cell) were 
used for the transduction. Transduction efficiency was scored at 20 h pi by measuring 
GFP signal intensity over nucleus, and is expressed as infection index (number of 
GFP positive nuclei/total number of nuclei). The values represent mean values from 
three technical replicates ± standard deviations.  
B) qRT-PCR control of knockdown efficiencies in shRNA-expressing cells. Transcripts 
analyzed are indicated on the upper part of the panel, and the annotation on x-axis 
indicates shRNA-expressing cell lysates used for analyses. The transcript levels are 
normalized to the wild type MPI-2 cells by three or two house-keeping genes.  
C) Transduction assay with HAdV-C5_dE1_GFP on MPI-2 cells expressing shRNA 
against SR-A6 or a control, non-targeting SR-A6_C911 shRNA. 
D) Transduction assay with HAdV-C5_dE1_GFP on MPI-2 and A549 cells after pre-
incubation of cells with three different concentrations of anti-SR-A6 antibody ED31 or 
an isotype-matched control antibody.  
E) Transduction assay with HAdV-C5_dE1_GFP on MPI-2 and A549 cells after pre-
incubation of virus with three different amounts of soluble mouse SR-A6. Input virus 
~16700 virus particles per cell with the soluble SR-A6. 
F) Transduction assay with HAdV-C5_dE1_GFP on wild type MPI-2 and two 
independent SR-A6-/- MPI-cell lines.  
G) Secretion of IFN α/β from wild type, SR-A6 knock-out or scavenger receptor 
shRNA-expressing MPI-2 cells upon HAdV-C5 infection. Culture medium was 
collected from virus-infected cells 24h pi and titrated on a reporter cell line expressing 
the Firefly luciferase gene under the control of an IFN-inducible Mx2 promoter.  
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Fig. 2: SR-A6 facilitates virus binding to MPI-2 cells 
A) Binding of Alexa Fluor488-labeled HAdV-C5 to parental MPI-2 cells or the mSR-A6-
/- M3 and M2-4 cell lines. Virus was added to cells at +4°C for 60 min (moi ~ 2540 virus 
particles per cell)  and cells were shifted to 37°C for 5min before analysis. The plot 
shows number of bound virus particles per cell, one dot representing one cell. Error 
bars represent the means ± SEMs. The difference between SR-A6-positive and SR-A6 
knockout cells was statistically significant (P<0.0001, Kolmogorov-Smirnov test). The 
right-hand panel shows representative images from the three cell lines analyzed. 
Images are maximum projections of confocal stacks. Virus particles are shown in 
green and nuclei (DAPI) in blue. Scale bar = 10 µm.  
B) Effect of preincubation of HAdV-C5 with three different amounts of soluble 
extracellular domain of mouse SR-A6. Input virus ~44600 virus particles per cell with 
the soluble SR-A6. The soluble form of SR-A6 in a concentration-dependent manner 
either suppressed virus binding to cells or caused virus to bind to cells in clustered 
forms. Scale bar = 10 µm.  
C) Representative negative stain EM images of HAdV-C5 incubated in the presence or 
absence of soluble, partially trimeric SR-A6. Scale bar = 0.5 µm.  
D) Proximity ligation assay indicates co-localization of virus and SR-A6 at the cell 
surface. Alexa Fluor488-conjugated HAdV-C5 was added to cells at 4°C for 60 min 
(moi ~1370 virus particles per cell), and proximity ligation assay was performed with 
anti-Alexa-Fluor488 antibodies and anti-SR-A6 ED31 antibody. Images shown 
represent maximum projections of confocal stacks. PLA indicates signal from the 
proximity ligation assay, virus panel shows the Alexa Fluor488-labeled virus particles 
and the overlay panel demonstrates the overlap of PLA and virus signals. Nuclei 
(DAPI stain) are in blue. Scale bar = 10 µm.  
E) Exogenous expression of murine SR-A6 in the CAR-negative L-929 cells promotes 
binding of HAdV-C5 to the cells. SR-A6 was expressed in the cells from a bi-cistronic 
mRNA which also directed the synthesis of Tomato from an internal translation 
initiation site. Alexa Fluor488- labeled HAdV-C5 particles were bound to transfected L-
929 cells at 4°C. Fixed samples were imaged by confocal microscopy. Virus particles 
associated with Tomato-positive and –negative cells were scored from maximum 
projections of confocal stacks. The plot shows number of virus particles per cell, one 
dot representing one cell. Horizontal bars represent mean values. Number of cells 
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analyzed is indicated. The difference between Tomato-positive and -negative cells was 
statistically significant (P<0.0001, Kolmogorov-Smirnov test).  
F) Exogenous expression of murine SR-A6 in L-929 cells promotes HAdV-C5-
mediated gene transduction. Transfected L-929 cells were infected with two different 
amounts of HAdV-C5_dE1_GFP, and nuclear GFP signals were scored at 24h post 
infection by microscopy. The plot shows mean nuclear GFP intensities for Tomato-
positive and –negative cells as Tukey box plots. More than 700 cells were analyzed for 
each sample. 
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Fig. 3: HVR1 on hexon controls binding of HAdV-C5 to MPI-2 cells 
A) Pre-incubation of cells with soluble HAdV-C5 fiber knobs (FK) does not inhibit 
binding of HAdV-C5 to MPI-2 cells, whereas binding of the virus to the CAR-positive 
A549 cells is suppressed in a dose-dependent manner. Cells were first pre-incubated 
with the indicated amounts of FKs and Atto565-labeled HAdV-C5 was then added to 
the cells at 4°C for 60 min (moi ~ 20000 and 38000 virus particles/cell for MPI-2 and 
A549, respectively). After removal of unbound viruses and fixation, cells were imaged 
by confocal microscopy and cell-associated virus particles were scored from maximum 
projections of confocal stacks. The plot shows number of bound virus particles per cell, 
one dot representing one cell. Error bars represent the means ± SEMs. Number of 
cells analyzed is indicated. The difference between MPI-2 FK 0 and 5 µg/ml or 1 µg/ml 
samples was statistically significant (P=0.002 and P=0.032, respectively, Kolmogorov-
Smirnov test). 
B) HAdV-A31 (with a truncated HVR1) binds better to SR-A6 negative M2-4 than MPI-
2 cells, and HVR1 swop HAdV-C5_HVR1(A31)/HVR7* shows reduced binding to MPI-
2 cells compared to HAdV-C5. The HVR1 swop was engineered into a virus backbone 
that carried single amino acid changes in hexon HVR7 (HVR7*), which prevent 
coagulation factor X binding to the virus. The experiment was carried out as described 
in (C). The difference between HAdV-C5_HVR1(A31)/HVR7* MPI-2 and M2-4 results, 
as well as that of HAdV-A31 results, is statistically significant (P<0.0001, Kolmogorov-
Smirnov test). The HVR1 amino acid sequences of HAdV-C5 (highlighted in red), 
HAdV-A31 (blue) and HAdV-C5_HVR1(A31)/HVR7* (blue, red) are shown in single 
letter code. 
C) HVR1 ablation reduces HAdV-C5 binding to MPI-2 cells but not A549 cells. 
Indicated amounts (vp) of unlabeled wild type HAdV-C5, HAdV-C5_HVR7* and HAdV-
C5_HVR1(A31)/HVR7* were added to ~ 1.6×105 cells at 4°C for 60 min and after 
removal of unbound virus, cells were switched to 37°C for 10 min before fixation. 
Viruses were detected by immunostaining with an anti-hexon 9C12 antibody and 
secondary Alexa Fluor488-conjugated antibody. Samples were imaged by confocal 
microscopy and cell-associated virus particles were scored from maximum projections 
of confocal stacks. The plot shows number of bound virus particles per cell, one dot 
representing one cell. Error bars represent the means ± SEMs. Number of cells 
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analyzed is indicated. The difference between HVR1(A31)/HVR7* and the wild type or 
HVR7* viruses  was statistically significant in MPI-2 cells (P=0.0091 and P=0.0006 for 
the vp 13×108 samples, respectively, Kolmogorov-Smirnov test), whereas differences 
in A549 cells were not statistically significant.  
D) Swop of hexon HVR1 with that of HAdV-A31 reduces HAdV-C5 gene transduction 
in MPI-2 cells, but not in A549 cells. Cells (~4×104) were infected with the indicated 
amounts of HAdV-C5_HVR7* and HAdV-C5_HVR1(A31)/HVR7* viruses and the 
activity of firefly luciferase expressed from the viral genomes was used to estimate the 
transduction efficiencies at 24 h pi. The plot shows results from two technical 
replicates.  
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Fig. 4: Characterization of HAdV-C5 entry into MPI-2 cells 
A) Entry of HAdV-C5 into MPI-2 cells promotes structural changes on the virus 
particles that lead to exposure of the viral membrane lytic protein VI. Atto565-labeled 
HAdV-C5 were added to MPI-2 cells at 4°C (moi ~13600 virus particles per cell) for 60 
min. Unbound particles were washed away, and cells were shifted to 37°C for the 
indicated times. Intact cells were then incubated with 9C12 anti-hexon antibodies at 
4°C to tag surface-associated viruses, and after fixation, cells were permeabilized and 
stained for protein VI. Secondary Alexa Fluor680-conjugated anti-mouse and Alexa-
Fluor488-conjugated anti-rabbit antibodies were used to detect 9C12 and anti-protein 
VI antibodies, respectively. Nuclei were stained with DAPI, and samples were imaged 
by confocal microscopy. Virus particles lacking the 9C12 signal were scored as 
internalized particles and the left-hand plot shows percentage of internalized virus 
particles per cell at the different time points. One dot represents one cell. The right-
hand plot shows mean average protein VI signal on internalized particles. One dot 
represents one cell. Error bars represent the means ± SEMs. Number of cells 
analyzed is indicated.  
B) SR-A6-facilitated entry supports efficient penetration of HAdV-C5 into the 
cytoplasm. Alexa Fluor488-conjugated HAdV-C5 were added to MPI-2 cells at 4°C for 
60 min (moi ~7300 virus particles per cell). Unbound viruses were washed away and 
cells were shifted to 37°C for 45 min. Cell surface and cytoplasmic particles were 
tagged with anti-Alexa Fluor488 antibodies after perforation of the plasma membrane 
with streptolysin O (SLO). The anti-Alexa Fluor488 antibodies in turn were visualized 
by secondary Alexa Fluor594 antibodies. Control cells were incubated with antibodies 
without SLO treatment to specifically mark virus particles at the plasma membrane. 
The plot shows percentage of virus particles positive for the anti-Alexa Fluor488 
antibodies, one dot representing one cell. The majority of antibody-positive particles in 
the SLO-treated HAdV-C wild type (wt) sample represent cytoplasmic virus, since the 
no-SLO control indicated only few particles at the cell surface. Virus particles in the 
endosomes are inaccessible to the antibodies, and the endosomes stayed intact in the 
assay, since parallel samples infected with the penetration deficient HAdV-C2-TS1 
mutant virus displayed only low number of antibody-positive particles. Error bars 
represent the means ± SEMs. Numbers of cells and virus particles analyzed are 
indicated.   
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C) Tracking of incoming virus genome. EdC-labeled HAdV-C5 particles (moi ~ 7300 
virus particles per cell) were internalized into MPI-2 cells at 37°C for 30 min and, after 
removal of unbound virus, the samples were incubated for further 270 min before 
fixation. The virus capsids were visualized by anti-hexon 9C12 and Alexa Fluor594-
conjugated secondary antibodies, and click-reaction with Alexa Fluor488-conjugated 
azide was carried out to mark the virus genomes. The image represents maximum 
projection of image stack from central parts of the cells. Nuclear area and cell outline 
are indicated. In the majority of cells, the virus genome was separated from the capsid 
at this time point and concentrated over the nuclear area, as exemplified by the upper 
cell in the image. A fraction of cells displayed significant amounts of capsid-free virus 
DNA also in the cytoplasm, as exemplified by the lower cell in the image. Scale bar =  
5 µm. 
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Fig. 5: SR-A6 facilitates binding of HAdV-C2, HAdV-D26 and HAdV-B35 to MPI-2 
cells 
A) Alexa Fluor488-labeled virus particles were added to wild type MP1-2 or to the SR-
A6 knockout M2-4 cells as described in the legend to Fig.2A . Images shown are 
maximum projections of confocal stacks. Virus particles are pseudo-colored green and 
nuclei (DAPI) blue. Scale bar = 10 µm. The plots show quantification of virus binding 
efficiency, expressed as percentage of cell area covered by virus particles. Error bars 
represent the means ± SEMs, and number of cells analyzed is indicated. The 
difference in virus binding to MPI-2 and M2-4 cells was statistically significant for all 
viruses (P<0.0001, Kolmogorov-Smirnov test).  
B) SR-A6 facilitates HAdV-D26 and HAdV-B35 virus transduction. Wild type MPI-2 and 
the SR-A6 knockout M2-4 cells (~8×104) were infected with indicated amounts of 
recombinant virus vectors carrying the Firefly luciferase gene, and the luciferase 
enzyme activity in cell extracts was used to estimate the virus transduction efficiencies 
at 20.5 h pi. The plot shows results from two technical replicates.  
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Fig. 6: High surface expression of human SR-A6 facilitates HAdV-C5 infection 
A) Exogenous expression of human SR-A6 in L-929 cells (low CAR expression) 
promotes binding of HAdV-C5 to the cells. L-929 cells were transfected with a plasmid 
directing the synthesis of human SR-A6 from the cytomegalovirus major immediate 
early promoter and transfected cells were identified by immunostaining with anti-
human SR-A6 antibody PLK1. Alexa Fluor488-labeled HAdV-C5 particles were added 
to transfected L-929 cells at 4°C for 60 min. Fixed samples were imaged by confocal 
microscopy and virus particles associated with PLK1-positive and PLK1-negative cells 
were scored from maximum projections of confocal stacks. The plot shows number of 
virus particles per cell, one dot representing one cell. Horizontal bars represent mean 
values. Number of cells analyzed is indicated. The difference between PLK1-positive 
and -negative cells was statistically highly significant (P<0.0001, Kolmogorov-Smirnov 
test). The right-hand panel shows a representative image as a maximum projection of 
confocal stacks. In the overlay panel virus particles are shown in green, SR-A6-
positive cells in red and nuclei (DAPI) in blue. Scale bar = 10 µm. 
B) Exogenous expression of human SR-A6 in HDF-TERT cells boosts HAdV-C5-
mediated gene transduction. SR-A6 was expressed in the cells from a plasmid that 
directed synthesis of the protein from a bi-cistronic SR-A6-IRES-Tomato mRNA. 
Transfected HDF-TERT cells were infected with two different amounts of HAdV-
C5_dE1_GFP, and nuclear GFP signals were scored at 30 h post infection (pi) by 
microscopy. Non-transfected cells or cells transfected with an empty vector were used 
as controls. The mean nuclear GFP intensities of Tomato-positive and Tomato-
negative cells are shown as Tukey box plots. The difference between Tomato-positive 
and Tomato-negative cells in the SR-A6 transfection was statistically highly significant 
with a P-value <0.0001 (Kolmogorov-Smirnov test), whereas the difference in empty 
vector transfections did not reach P<0.0001 significance levels. Over 300 Tomato-
positive cells and more than 5000 Tomato-negative cells were scored for each sample.  
C) Mouse SR-A6 expression in HDF-TERT cells leads to higher HAdV-C5_dE1_GFP 
infection efficiency than human SR-A6 expression. Both mouse (mSR-A6) and human 
(hSR-A6) proteins were expressed from bi-cistronic SR-A6-IRES-Tomato mRNAs. The 
mean nuclear GFP intensities of Tomato-positive and Tomato-negative cells are 
shown as Tukey box plots. Over 500 Tomato-positive cells and more than 4500 
Tomato-negative cells were scored for each sample. 
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Supporting information captions 
S1 Figure: Analyses of scavenger receptor expression in MPI-2 cells 
 
S2 Figure: Virus binding to scavenger receptor knockdown MPI-2 cells 
 
S3 Figure: Effect of hexon HVR1 on binding of HAdV-C5 to MPI-2 cells 
 
S4 Figure: HAdV-C5 entry into MPI-2 cells 
 
S5 Figure: Comparison of HAdV-C5, HAdV-B35 and HAdV-D26 binding to 
MPI-2 cells 
 
S6 Figure: Surface expression of human SR-A6 correlates with Tomato 
signal in transfected HDF-TERT cells 
 
S7 Figure: Location of HVR1 on hexon and comparison of HAdV HVR1 
sequences of viruses used in the study 
 
S1 Table: Oligonucleotides used for cloning of constructs expressing 
shRNAs against mouse scavenger receptors 
 
S2 Table: Oligonucleotides used for qRT-PCR 
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Supporting information 
S1 Figure: Analyses of scavenger receptor expression in MPI-2 cells 
A) Analyses of surface expression of SR-A6 in wild type MPI-2 cells and in SR-A6 
knockout M3 and M2-4 cells by flow cytometry. FITC-conjugated rat anti-mouse SR-A6 
ED31 antibody was used in the assay. Graphs show histograms of Alexa Fluor488 
channel in overlay and single panels, as well as mean and median read-outs.  
B) Determination of SR-A1, SR-A6, SR-B1 and SR-B2 transcript levels in MPI-2, M3 and 
M2-4 cells by qRT-PCR. The transcript levels are normalized to the wild type MPI-2 cells 
by three house-keeping genes.  
C) Secretion of IFN !/" from HAdV-C5-infected parental MPI-2 cells or MPI-2 cells 
expressing either an shRNA directed against SR-A6 or a control C911 non-targeting 
shRNA. Culture media from the infected cells were titrated on a reporter cell line 
expressing the Firefly luciferase gene under the IFN-inducible Mx2 promoter. 
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S2 Figure: Virus binding to scavenger receptor knockdown MPI-2 cells 
A) Binding of Alexa Fluor 488-labeled HAdV-C5 to MPI-2 cells expressing shRNAs against 
the scavenger receptors SR-A1, SR-A6, SR-B1 or SR-B2. Viruses were added to cells for 
60 min at 4° (moi ~2655 virus particles per cell). Quantifications of bound virus particles 
per cell and representative images (maximum projections of confocal stacks) are shown. 
The difference between no shRNA and shSR-A6 cells was statistically significant 
(P<0.0001, Kolmogorov-Smirnov test), but the differences between no shRNA and shSR-
A1, shSR-B1 or shSR-B2 cells were not significant. Viruses are pseudo-colored green and 
nuclei (DAPI stain) blue. Scale bar = 10 µm. 
B) Binding of Alexa Fluor 488-labeled HAdV-C5 to MPI-2 cells expressing the non-
targeting C911 control shRNA against SR-A6. Viruses were added to cells for 60 min at 
4°C (moi ~8855 particles per cell). Quantifications of bound virus particles per cell and 
representative images (maximum projections of confocal stacks) are shown for each cell 
line. Viruses are pseudo-colored green and nuclei (DAPI stain) blue. Scale bar = 10 µm.  
C) Comparison of binding of Alexa Fluor488-labeled HAdV-B3 to MPI-2 and A549 cells. 
Viruses were added to cells for 60 min at 4°C (MPI-2 ~43400 virus particles and A549 
~4270 virus particles per cell) and the binding efficiencies were analyzed from fixed cells 
by confocal microscopy. The images shown represent maximum projections of confocal 
stacks. The amounts of input virus are indicated. In the overlay panel viruses are pseudo-
colored green and nuclei (DAPI stain) blue. Scale bar = 10 µm.  
D) HAdV-B3 remains mono-dispersed after incubation with soluble mouse SR-A6. 
Representative negative stain EM images of HAdV-B3 incubated in the presence or 
absence of soluble SR-A6. Scale bar = 500 nm.   
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S3 Figure: Effect of hexon HVR1 on binding of HAdV-C5 to MPI-2 cells 
A) HAdV-C5_wild type (WT), HAdV-C5_HVR7* and HAdV-C5_HVR1(A31)/HVR7* virus 
preparations were analyzed by SDS-PAGE (8% gel) and silver staining to verify virus 
concentrations determined by absorbance measurements at 260 nm. Virus amounts 
loaded on the gel are indicated, as well as the position of viral proteins II (hexon), III 
(penton base), IV (fiber) and V.  
B) Representative images showing binding of HAdV-C5_wild type (WT), HAdV-C5_HVR7* 
and HAdV-C5_HVR1(A31)/HVR7* virions to MPI-2 and A549 cells. Input virus amounts in 
MPI-2 cells were 26×108 virions for HAdV-C5_wild type and HAdV-C5_HVR7*, and 40×108 
virions for HAdV-C5_HVR1(A31)/HVR7*, whereas 52×108 virions of HAdV-C5_wild type 
and HAdV-C5_HVR7* or 40×108 virions of HAdV-C5_HVR1(A31)/HVR7* were added to 
A549 cells at 4°C for 60 min. The images show maximum projections of confocal stacks. 
Virions are shown in green and DAPI-stained nuclei in blue. Scale bar = 10 µm.  
C) Representative images showing the effect of hexon HVR1 on binding of HAdV-C5 and 
HAdV-A31 to MPI-2 and M2-4 (SR-A6 knockout) cells. Input virus amounts for HAdV-
C5_HVR7* and HAdV-C5_HVR1(A31)/HVR7* were 21×108 and 30×108 virions, 
respectively, and 120×108 virions for HAdV-A31. The images show maximum projections 
of confocal stacks. Virions are shown in green (HAdV-C5_HVR7* and HAdV-
C5_HVR1(A31)/HVR7*) or red (HAdV-A31), and DAPI-stained nuclei in blue. The Atto565 
labeling caused partial clustering of HAdV-A31. Scale bar = 10 µm. 
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S4 Figure: HAdV-C5 entry into MPI-2 cells 
A) Representative images showing protein VI externalization upon virus entry into MPI-2 
cells. The DAPI-stained nuclei are shown in blue. Scale bar = 10 µm.  
B) Representative images for tracking of incoming virus DNA in HAdV-C5-infected MPI-2 
cells. The image for the 30 min time point is a maximum projection of a confocal stack 
through the entire cell volume. Nuclear and cell outlines are indicated. Empty capsid (red) 
signals in the nuclear area represent capsid remnants below or above the nucleus, 
whereas the nucleus-associated uncoated DNA (green) can signify either DNA imported 
into the nucleus, DNA associated with the cytoplasmic side of the nuclear envelope or 
DNA above or below the nucleus. For the 270 min time point image, confocal slices below 
and above the nucleus were excluded from the maximum projection, and thus the nucleus-
associated uncoated DNA is expected to largely represent DNA imported into the nucleus. 
Scale bar = 5 µm. 
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S5 Figure: Comparison of HAdV-C5, HAdV-B35 and HAdV-D26 binding to MPI-
2 cells 
Alexa Fluor488-labeled viruses (moi ~1000 virus particles per cell) were added to cells at 
4°C for 60 min, and after removal of unbound virus, cells were incubated at 37°C for 10 
min before fixation. Cells were imaged by confocal microscopy and cell-associated virus 
particles were scored from maximum projections of confocal stacks. The plot shows 
number of bound virus particles per cell, one dot representing one cell. Error bars 
represent the means ± SEMs. Number of cells analyzed is indicated. 
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S6 Figure: Surface expression of human SR-A6 correlates with Tomato signal 
in transfected HDF-TERT cells 
Representative images showing surface expression of human SR-A6 in HDF-TERT cells 
transfected with a plasmid that directed the synthesis of a bi-cistronic SR-A6-IRES-Tomato 
mRNA. Control cells were transfected with the empty plasmid backbone. Forty hours post 
transfection intact cells were incubated with the anti-human SR-A6 PLK1 antibody at 0°C, 
fixed, incubated with Alexa-Fluor488-conjugated secondary anti-mouse antibodies and 
DAPI-stained. Images are maximum projections of confocal stacks. Transfected cells 
displayed variable levels of SR-A6 at the cell surface, and by visual inspection, the 
intensity of surface SR-A6 signal correlated with the intensity of the Tomato signal. No 
PLK1 antibody signal was detected on non-transfected Tomato-negative cells or on 
Tomato-positive cells in the control transfection. Scale bar = 10 µm.   
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S7 Figure: Location of HVR1 on hexon and comparison of HAdV HVR1 sequences of 
viruses used in the study 
A) Ad5 hexon (PDB ID code 6B1T) is depicted in blue and ribbon corresponding to 
residues WDEAATALEINLEEEDDDNEDEVDEQAEQQKTHVFGQ, including the 
HVR1 as defined by [1, 2], is highlighted in red using the molecular visualization 
program UCSF Chimera. The stretch of amino acids which appears to influence 
SR-A6 binding is exposed on the surface near the rim of the cup formed in the 
hexon trimer. 
B) The HVR1 hexon loops of HAdV-C2 and HAdV-C5 were assigned according to [1], 
and are indicated in red. The sequence alignment was done using Clustal Omega 
at EMBL-EBI [3]. 
 
 
C2 YNALAPKGAPNSCEWEQTEDSGRAVAEDEEEEDEDEEEEEEEQNARDQATKKTHVYAQAP
C5   YNALAPKGAPNPCEWDEAATALEINLEEEDDDNEDEV------------DEQAEQQKTHVFGQAP
B3   YNSLAPKGAPNTSQWIVTTNGDNAV-----------------------------TTTTNTFGIAS
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S1 Table: Oligonucleotides used for cloning of constructs expressing 
shRNAs against mouse scavenger receptors 
 
  
Supplementary,Table,1.,Oligos'used'for'cloning'of'constructs'expressing'shRNAs'against'mouse'
scavenger'receptors.'
 
SR#A1& 5’#&GATCCCGCAACTGACCAAAGACTTAATGTGTGCTGTCCATTAAGTCTTTGGTCAGTTGCTTTTTGGAAA#3’&5’#AGCTTTTCCAAAAAGCAACTGACCAAAGACTTAATGGACAGCACACATTAAGTCTTTGGTCAGTTGCGG#3’&SR#A6& 5‘#GATCCCGGGTGACACAGGAATTCAAGGGTGTGCTGTCCCCTTGAATTCCTGTGTCACCCTTTTTGGAAA#3‘&5‘#AGCTTTTCCAAAAAGGGTGACACAGGAATTCAAGGGGACAGCACACCCTTGAATTCCTGTGTCACCCGG#3‘&SR#A6#C911& 5‘#GATCCCGGGTGACAGTCGAATTCAAGGGTGTGCTGTCCCCTTGAATTCGACTGTCACCCTTTTTGGAAA#3‘&5‘#AGCTTTTCCAAAAAGGGTGACAGTCGAATTCAAGGGGACAGCACACCCTTGAATTCGACTGTCACCCGG#3‘&SR#B1&&&&&&&&&& 5’#GATCCCGCAGCAGGTGCTCAAGAATGTGTGTGCTGTCCACATTCTTGAGCACCTGCTGCTTTTTGGAAA#3’&5’AGCTTTTCCAAAAAGCAGCAGGTGCTCAAGAATGTGGACAGCACACACATTCTTGAGCACCTGCTGCGG#3’&SR#B2& 5’#GATCCCGGATAACATAAGCAAAGTTGCGTGTGCTGTCCGCAACTTTGCTTATGTTATCCTTTTTGGAAA#3’&5’AGCTTTTCCAAAAAGGATAACATAAGCAAAGTTGCGGACAGCACACGCAACTTTGCTTATGTTATCCGG#3’&
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S2 Table: Oligonucleotides used for qRT-PCR 
 
 
 
Supplementary,Table,2.,Oligos'used'for'qRT0PCR.''' mSR0A1' ' 5’0TGCTGTCTTCTTTACCAGCA03’'' ' '''''''''''''''5’0TGAAGGGAGGGGCCATTTTT03’'mSR0A6' ' 5’0AGGAAGACTTCTTGGGCAGC03’'' ' '''''''''''''''5’0GAGCAGGATCAGGTGGATGG03’'mSR0B1' ' 5’0'GCCCCAGGTTCTTCACTACG03’'' ' '''''''''''''''5’0'TCCTCAAGAAGCGGGGTGTA03’'mSR0B2' ' 5’0'CAGCTCATACATTGCTGTTTATGC03’'' ' '''''''''''''''5’0'ACTGGTTTTCTCGCCAACTC03’'mEEF1A1' '''''''''''''''5’0TCCACTTGGTCGCTTTGCT%3’(
( ( ((((((((((((((5’%CTTCTTGTCCACAGCTTTGATGA%3’'
mTBP( ( ((((((((((((((5’%TTGACCTAAAGACCATTGCACTTC%3’(
( ( ((((((((((((((5’%TTCTCATGATGACTGCAGCAAA%3’'
mGAPDH( ((((((((((((((5’%'TGGAGTCTACTGGTGTCTTCAC03’(
( ( ((((((((((((((5’%'TTTTGGCTCCACCCTTCAAG03’(
('
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